Comparison

dagrocorat

Item no. V4491-25mg
Manufacturer InvivoChem LLC
CASRN 1044535-52-5
Amount 25 mg
Quantity options 10 mg 1 mg 50 mg
Category
Type Biochemicals
Specific against other
ECLASS 10.1 32160490
ECLASS 11.0 32160490
UNSPSC 12000000
Available
Description
InvivoChem Cat #:V4491CAS #:1044535-52-5Purity >=98%

Description: Dagrocorat (also known as PF-00251802) is a novel and potent dissociated glucocorticoid receptor agonist with the potential usefulness as an anti-inflammatory agent. The dissociated agonists of the glucocorticoid receptor are a novel class of agents in clinical development for rheumatoid arthritis. PF-04171327 (fosdagrocorat) is a phosphate ester prodrug of PF-00251802 (dagrocorat), a selective high-affinity partial agonist of the glucocorticoid receptor, which is further metabolized to PF-04015475. PF-00251802 is a reversible inhibitor of several CYPs, but modeling has suggested no clinically relevant interaction. PF-00251802 and PF-04015475 are time-dependent inhibitors and inducers of CYP3A in vitro; PF-00251802 is also a time-dependent inhibitor of CYP2D6. Model-based prediction suggested the potential for weak inhibition of CYP3A in vivo. A clinical DDI study was conducted with midazolam, a sensitive CYP3A substrate. A phase 1 open-label, multiple-dose study evaluated the effect of PF-04171327 on midazolam pharmacokinetics and safety in 12 healthy volunteers. Administration of midazolam alone or concomitantly with PF-04171327 resulted in equivalent pharmacokinetic profiles (AUCinf , 21.17 vs 20.28 ng·h/mL, respectively), indicating that PF-04171327 had no net effect on CYP3A activity in vivo. These findings support the further development of PF-00251802 and PF-04171327 as potential treatments for patients with rheumatoid arthritis (NCT00987038).

References: 2018 Mar; 7(3):244-255.

Related CAS: 1044535-58-1 (Fosdagrocorat)

Dagrocorat

Name: Dagrocorat
CAS#: 1044535-52-5
Chemical Formula: C29H29F3N2O2
Exact Mass: 494.2181
Molecular Weight: 494.5582
Elemental Analysis: C, 70.43; H, 5.91; F, 11.52; N, 5.66; O, 6.47
Storage
-20C for 3 years in powder form
-80C for 2 years in solvent
Technical Information
Synonym: PF-251802; PF 251802; PF251802; PF-00251802; PF 00251802; PF00251802;
IUPAC/Chemical Name: (4bR, 7S, 8aR)-4b-benzyl-7-hydroxy-N-(2-methylpyridin-3-yl)-7-(trifluoromethyl)-4b, 5, 6, 7, 8, 8a, 9, 10-octahydrophenanthrene-2-carboxamide
InChi Key: QJJBNCHSWFGXML-QPVYNBJUSA-N
InChi Code: InChI=1S/C29H29F3N2O2/c1-19-25(8-5-15-33-19)34-26(35)22-10-12-24-21(16-22)9-11-23-18-28(36, 29(30, 31)32)14-13-27(23, 24)17-20-6-3-2-4-7-20/h2-8, 10, 12, 15-16, 23, 36H, 9, 11, 13-14, 17-18H2, 1H3, (H, 34, 35)/t23-, 27-, 28+/m1/s1
SMILES Code: FC([C]1(O)CC[C]2(CC3=CC=CC=C3)C4=CC=C(C(NC5=CC=CN=C5C)=O)C=C4CC[C]2([H])C1)(F)F

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 25 mg
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close